G

Researcher Profile

Gregory M Lubiniecki

2

Publications

8,008

Citations

10

Co-Authors

2

Active Years

Publications

Journal Article The Lancet May 01, 2019

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony S K Mok · Yi-Long Wu · Iveta Kudaba · Dariusz M Kowalski +246 more

10.1016/s0140-6736(18)32409-7 2,753 citations

Journal Article The Lancet Apr 01, 2016

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S Herbst · Paul Baas · Dong-Wan Kim · Enriqueta Felip +15 more

10.1016/s0140-6736(15)01281-7 5,255 citations

Publication Timeline

2019

1

2016

1

Frequent Co-Authors

Pedro Rafael Martins De Marchi

Atsushi Horiike

Touch Ativitavas